Cardiovascular manifestations and treatment considerations in COVID-19.
Identifieur interne : 001823 ( Main/Corpus ); précédent : 001822; suivant : 001824Cardiovascular manifestations and treatment considerations in COVID-19.
Auteurs : Yu Kang ; Tiffany Chen ; David Mui ; Victor Ferrari ; Dinesh Jagasia ; Marielle Scherrer-Crosbie ; Yucheng Chen ; Yuchi HanSource :
- Heart (British Cardiac Society) [ 1468-201X ] ; 2020.
English descriptors
- KwdEn :
- Angiotensin Receptor Antagonists (therapeutic use), Angiotensin-Converting Enzyme 2 (MeSH), Angiotensin-Converting Enzyme Inhibitors (therapeutic use), Anticoagulants (therapeutic use), Azithromycin (therapeutic use), Betacoronavirus (MeSH), Biomarkers (blood), COVID-19 (MeSH), Cardiovascular Diseases (epidemiology), Cardiovascular Diseases (therapy), Chloroquine (therapeutic use), Comorbidity (MeSH), Coronavirus Infections (epidemiology), Coronavirus Infections (mortality), Cytokine Release Syndrome (epidemiology), Disseminated Intravascular Coagulation (epidemiology), Extracorporeal Membrane Oxygenation (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Immunosuppressive Agents (therapeutic use), Influenza, Human (mortality), Lung (metabolism), Lung (pathology), Myocardium (metabolism), Myocardium (pathology), Pandemics (MeSH), Peptidyl-Dipeptidase A (metabolism), Pneumonia, Viral (epidemiology), SARS-CoV-2 (MeSH), Severe Acute Respiratory Syndrome (mortality), Troponin (blood), Venous Thromboembolism (epidemiology), Venous Thromboembolism (prevention & control).
- MESH :
- chemical , blood : Biomarkers, Troponin.
- chemical , metabolism : Peptidyl-Dipeptidase A.
- chemical , therapeutic use : Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Anticoagulants, Azithromycin, Chloroquine, Hydroxychloroquine, Immunosuppressive Agents.
- chemical : Angiotensin-Converting Enzyme 2.
- epidemiology : Cardiovascular Diseases, Coronavirus Infections, Cytokine Release Syndrome, Disseminated Intravascular Coagulation, Pneumonia, Viral, Venous Thromboembolism.
- metabolism : Lung, Myocardium.
- mortality : Coronavirus Infections, Influenza, Human, Severe Acute Respiratory Syndrome.
- pathology : Lung, Myocardium.
- prevention & control : Venous Thromboembolism.
- therapy : Cardiovascular Diseases.
- Betacoronavirus, COVID-19, Comorbidity, Extracorporeal Membrane Oxygenation, Humans, Pandemics, SARS-CoV-2.
Abstract
Since its recognition in December 2019, covid-19 has rapidly spread globally causing a pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular disease are associated with a greater severity and higher fatality rate of covid-19. Furthermore, COVID-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest. The cardiovascular interactions of COVID-19 have similarities to that of severe acute respiratory syndrome, Middle East respiratory syndrome and influenza. Specific cardiovascular considerations are also necessary in supportive treatment with anticoagulation, the continued use of renin-angiotensin-aldosterone system inhibitors, arrhythmia monitoring, immunosuppression or modulation, and mechanical circulatory support.
DOI: 10.1136/heartjnl-2020-317056
PubMed: 32354800
PubMed Central: PMC7211105
Links to Exploration step
pubmed:32354800Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cardiovascular manifestations and treatment considerations in COVID-19.</title><author><name sortKey="Kang, Yu" sort="Kang, Yu" uniqKey="Kang Y" first="Yu" last="Kang">Yu Kang</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Tiffany" sort="Chen, Tiffany" uniqKey="Chen T" first="Tiffany" last="Chen">Tiffany Chen</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mui, David" sort="Mui, David" uniqKey="Mui D" first="David" last="Mui">David Mui</name><affiliation><nlm:affiliation>University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Ferrari, Victor" sort="Ferrari, Victor" uniqKey="Ferrari V" first="Victor" last="Ferrari">Victor Ferrari</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Jagasia, Dinesh" sort="Jagasia, Dinesh" uniqKey="Jagasia D" first="Dinesh" last="Jagasia">Dinesh Jagasia</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Scherrer Crosbie, Marielle" sort="Scherrer Crosbie, Marielle" uniqKey="Scherrer Crosbie M" first="Marielle" last="Scherrer-Crosbie">Marielle Scherrer-Crosbie</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Yucheng" sort="Chen, Yucheng" uniqKey="Chen Y" first="Yucheng" last="Chen">Yucheng Chen</name><affiliation><nlm:affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</nlm:affiliation></affiliation></author><author><name sortKey="Han, Yuchi" sort="Han, Yuchi" uniqKey="Han Y" first="Yuchi" last="Han">Yuchi Han</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA yuchi.han@pennmedicine.upenn.edu.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32354800</idno><idno type="pmid">32354800</idno><idno type="doi">10.1136/heartjnl-2020-317056</idno><idno type="pmc">PMC7211105</idno><idno type="wicri:Area/Main/Corpus">001823</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001823</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cardiovascular manifestations and treatment considerations in COVID-19.</title><author><name sortKey="Kang, Yu" sort="Kang, Yu" uniqKey="Kang Y" first="Yu" last="Kang">Yu Kang</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Tiffany" sort="Chen, Tiffany" uniqKey="Chen T" first="Tiffany" last="Chen">Tiffany Chen</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mui, David" sort="Mui, David" uniqKey="Mui D" first="David" last="Mui">David Mui</name><affiliation><nlm:affiliation>University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Ferrari, Victor" sort="Ferrari, Victor" uniqKey="Ferrari V" first="Victor" last="Ferrari">Victor Ferrari</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Jagasia, Dinesh" sort="Jagasia, Dinesh" uniqKey="Jagasia D" first="Dinesh" last="Jagasia">Dinesh Jagasia</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Scherrer Crosbie, Marielle" sort="Scherrer Crosbie, Marielle" uniqKey="Scherrer Crosbie M" first="Marielle" last="Scherrer-Crosbie">Marielle Scherrer-Crosbie</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Chen, Yucheng" sort="Chen, Yucheng" uniqKey="Chen Y" first="Yucheng" last="Chen">Yucheng Chen</name><affiliation><nlm:affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</nlm:affiliation></affiliation></author><author><name sortKey="Han, Yuchi" sort="Han, Yuchi" uniqKey="Han Y" first="Yuchi" last="Han">Yuchi Han</name><affiliation><nlm:affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA yuchi.han@pennmedicine.upenn.edu.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Heart (British Cardiac Society)</title><idno type="eISSN">1468-201X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Angiotensin Receptor Antagonists (therapeutic use)</term><term>Angiotensin-Converting Enzyme 2 (MeSH)</term><term>Angiotensin-Converting Enzyme Inhibitors (therapeutic use)</term><term>Anticoagulants (therapeutic use)</term><term>Azithromycin (therapeutic use)</term><term>Betacoronavirus (MeSH)</term><term>Biomarkers (blood)</term><term>COVID-19 (MeSH)</term><term>Cardiovascular Diseases (epidemiology)</term><term>Cardiovascular Diseases (therapy)</term><term>Chloroquine (therapeutic use)</term><term>Comorbidity (MeSH)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (mortality)</term><term>Cytokine Release Syndrome (epidemiology)</term><term>Disseminated Intravascular Coagulation (epidemiology)</term><term>Extracorporeal Membrane Oxygenation (MeSH)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Immunosuppressive Agents (therapeutic use)</term><term>Influenza, Human (mortality)</term><term>Lung (metabolism)</term><term>Lung (pathology)</term><term>Myocardium (metabolism)</term><term>Myocardium (pathology)</term><term>Pandemics (MeSH)</term><term>Peptidyl-Dipeptidase A (metabolism)</term><term>Pneumonia, Viral (epidemiology)</term><term>SARS-CoV-2 (MeSH)</term><term>Severe Acute Respiratory Syndrome (mortality)</term><term>Troponin (blood)</term><term>Venous Thromboembolism (epidemiology)</term><term>Venous Thromboembolism (prevention & control)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Biomarkers</term><term>Troponin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Peptidyl-Dipeptidase A</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Angiotensin Receptor Antagonists</term><term>Angiotensin-Converting Enzyme Inhibitors</term><term>Anticoagulants</term><term>Azithromycin</term><term>Chloroquine</term><term>Hydroxychloroquine</term><term>Immunosuppressive Agents</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Angiotensin-Converting Enzyme 2</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cardiovascular Diseases</term><term>Coronavirus Infections</term><term>Cytokine Release Syndrome</term><term>Disseminated Intravascular Coagulation</term><term>Pneumonia, Viral</term><term>Venous Thromboembolism</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Lung</term><term>Myocardium</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronavirus Infections</term><term>Influenza, Human</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung</term><term>Myocardium</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Venous Thromboembolism</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Cardiovascular Diseases</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Comorbidity</term><term>Extracorporeal Membrane Oxygenation</term><term>Humans</term><term>Pandemics</term><term>SARS-CoV-2</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Since its recognition in December 2019, covid-19 has rapidly spread globally causing a pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular disease are associated with a greater severity and higher fatality rate of covid-19. Furthermore, COVID-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest. The cardiovascular interactions of COVID-19 have similarities to that of severe acute respiratory syndrome, Middle East respiratory syndrome and influenza. Specific cardiovascular considerations are also necessary in supportive treatment with anticoagulation, the continued use of renin-angiotensin-aldosterone system inhibitors, arrhythmia monitoring, immunosuppression or modulation, and mechanical circulatory support.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32354800</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-201X</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>15</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Heart (British Cardiac Society)</Title><ISOAbbreviation>Heart</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular manifestations and treatment considerations in COVID-19.</ArticleTitle><Pagination><MedlinePgn>1132-1141</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/heartjnl-2020-317056</ELocationID><Abstract><AbstractText>Since its recognition in December 2019, covid-19 has rapidly spread globally causing a pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular disease are associated with a greater severity and higher fatality rate of covid-19. Furthermore, COVID-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest. The cardiovascular interactions of COVID-19 have similarities to that of severe acute respiratory syndrome, Middle East respiratory syndrome and influenza. Specific cardiovascular considerations are also necessary in supportive treatment with anticoagulation, the continued use of renin-angiotensin-aldosterone system inhibitors, arrhythmia monitoring, immunosuppression or modulation, and mechanical circulatory support.</AbstractText><CopyrightInformation>© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><Identifier Source="ORCID">http://orcid.org/0000-0003-3768-3143</Identifier><AffiliationInfo><Affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mui</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagasia</LastName><ForeName>Dinesh</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherrer-Crosbie</LastName><ForeName>Marielle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yucheng</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-0601-8039</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yuchi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-7582-1848</Identifier><AffiliationInfo><Affiliation>Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA yuchi.han@pennmedicine.upenn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL148103</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heart</MedlineTA><NlmUniqueID>9602087</NlmUniqueID><ISSNLinking>1355-6037</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057911">Angiotensin Receptor Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014336">Troponin</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.15.1</RegistryNumber><NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057911" MajorTopicYN="N">Angiotensin Receptor Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080424" MajorTopicYN="N">Cytokine Release Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004211" MajorTopicYN="N">Disseminated Intravascular Coagulation</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014336" MajorTopicYN="N">Troponin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="N">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac risk factors and prevention</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword><Keyword MajorTopicYN="N">systemic inflammatory diseases</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32354800</ArticleId><ArticleId IdType="pii">heartjnl-2020-317056</ArticleId><ArticleId IdType="doi">10.1136/heartjnl-2020-317056</ArticleId><ArticleId IdType="pmc">PMC7211105</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA. 2003 Jun 4;289(21):2801-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12734147</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Mar 27;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417</Citation><ArticleIdList><ArticleId IdType="pubmed">32172546</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Pathol. 2016 Mar;186(3):652-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26857507</ArticleId></ArticleIdList></Reference><Reference><Citation>Histopathology. 2018 Feb;72(3):516-524</Citation><ArticleIdList><ArticleId IdType="pubmed">28858401</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):382-386</Citation><ArticleIdList><ArticleId IdType="pubmed">32240123</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2016 Aug;49:129-33</Citation><ArticleIdList><ArticleId IdType="pubmed">27352628</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation><ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Feb 28;368:m810</Citation><ArticleIdList><ArticleId IdType="pubmed">32111649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 14;41(3):245-247</Citation><ArticleIdList><ArticleId IdType="pubmed">32133824</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2005 Jan 15;191(2):193-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15609228</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2020 May 26;141(21):e823-e831</Citation><ArticleIdList><ArticleId IdType="pubmed">32228309</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14408-14413</Citation><ArticleIdList><ArticleId IdType="pubmed">27911847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation><ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 Apr;8(4):420-422</Citation><ArticleIdList><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2018 Feb 23;67(7):205-211</Citation><ArticleIdList><ArticleId IdType="pubmed">29470455</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2018 Jan 25;378(4):345-353</Citation><ArticleIdList><ArticleId IdType="pubmed">29365305</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation><ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464</Citation><ArticleIdList><ArticleId IdType="pubmed">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>Respir Med. 2013 May;107(5):637-48</Citation><ArticleIdList><ArticleId IdType="pubmed">23352223</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation><ArticleIdList><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference><Reference><Citation>Infection. 2020 Apr 10;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32277408</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation><ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 2015 Mar 27;116(7):1254-68</Citation><ArticleIdList><ArticleId IdType="pubmed">25814686</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2020 Jun 9;141(23):1930-1936</Citation><ArticleIdList><ArticleId IdType="pubmed">32243205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2007 Aug;7(8):549-58</Citation><ArticleIdList><ArticleId IdType="pubmed">17646028</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Apr 6;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 Apr;18(4):844-847</Citation><ArticleIdList><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2003 Jul;200(3):282-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12845623</ArticleId></ArticleIdList></Reference><Reference><Citation>Catheter Cardiovasc Interv. 2020 Mar 25;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32212409</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 2004 Dec 10;95(12):1140-53</Citation><ArticleIdList><ArticleId IdType="pubmed">15591236</ArticleId></ArticleIdList></Reference><Reference><Citation>J Korean Med Sci. 2016 Nov;31(11):1717-1725</Citation><ArticleIdList><ArticleId IdType="pubmed">27709848</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Rep. 2014 Nov 13;4:7027</Citation><ArticleIdList><ArticleId IdType="pubmed">25391767</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 Jun 20;417(6891):822-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12075344</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2020 Apr;46(4):586-590</Citation><ArticleIdList><ArticleId IdType="pubmed">32125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 May;8(5):518-526</Citation><ArticleIdList><ArticleId IdType="pubmed">32203711</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1994 Dec 7;272(21):1661-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7966893</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2020 May;46(5):846-848</Citation><ArticleIdList><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2004 Jun 8;109(22):2698-704</Citation><ArticleIdList><ArticleId IdType="pubmed">15184294</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 May;581(7807):221-224</Citation><ArticleIdList><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Mar 06;48(0):E008</Citation><ArticleIdList><ArticleId IdType="pubmed">32141280</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pharm Res. 2003 Aug;26(8):631-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12967198</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathology. 2003 Dec;35(6):526-31</Citation><ArticleIdList><ArticleId IdType="pubmed">14660106</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 2020 May 14;41(19):1861-1862</Citation><ArticleIdList><ArticleId IdType="pubmed">32267502</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Mar 27;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenet Genomics. 2017 Apr;27(4):164-167</Citation><ArticleIdList><ArticleId IdType="pubmed">28146011</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Mar 25;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2020 Mar 3;141(9):e139-e596</Citation><ArticleIdList><ArticleId IdType="pubmed">31992061</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2012 Dec 1;206(11):1652-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23048170</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Feb 7;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Apr;55(4):105945</Citation><ArticleIdList><ArticleId IdType="pubmed">32194152</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hypertens. 1996 Jun;14(6):799-805</Citation><ArticleIdList><ArticleId IdType="pubmed">8793704</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975</Citation><ArticleIdList><ArticleId IdType="pubmed">32350134</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorax. 2003 Aug;58(8):686-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12885985</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2005 May 24;111(20):2605-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):473-475</Citation><ArticleIdList><ArticleId IdType="pubmed">32043983</ArticleId></ArticleIdList></Reference><Reference><Citation>Thromb Res. 2020 Jul;191:145-147</Citation><ArticleIdList><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Mar 19;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32191259</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Med. 2020 Apr;14(2):185-192</Citation><ArticleIdList><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>J Thromb Haemost. 2020 May;18(5):1094-1099</Citation><ArticleIdList><ArticleId IdType="pubmed">32220112</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheumatol. 2014 Sep;66(9):2613-20</Citation><ArticleIdList><ArticleId IdType="pubmed">24782338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jpn Heart J. 1977 Jan;18(1):57-69</Citation><ArticleIdList><ArticleId IdType="pubmed">846048</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation><ArticleIdList><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2013 Aug 23;347:f5061</Citation><ArticleIdList><ArticleId IdType="pubmed">23974637</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120</Citation><ArticleIdList><ArticleId IdType="pubmed">32172226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):769-74</Citation><ArticleIdList><ArticleId IdType="pubmed">24367104</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hypertens. 2020 May;38(5):781-782</Citation><ArticleIdList><ArticleId IdType="pubmed">32195824</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Cardiol. 2020 May;17(5):259-260</Citation><ArticleIdList><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Chemother. 2013 Jun;19(3):426-31</Citation><ArticleIdList><ArticleId IdType="pubmed">23089894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mod Pathol. 2020 Jun;33(6):1007-1014</Citation><ArticleIdList><ArticleId IdType="pubmed">32291399</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2004 Apr;136(1):95-103</Citation><ArticleIdList><ArticleId IdType="pubmed">15030519</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation><ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 23;382(17):1653-1659</Citation><ArticleIdList><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin Med J (Engl). 2020 May 5;133(9):1025-1031</Citation><ArticleIdList><ArticleId IdType="pubmed">32044814</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001823 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001823 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32354800
|texte= Cardiovascular manifestations and treatment considerations in COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32354800" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |